Data from EPG Health Media - Curated by Toby Galbraith - Last updated 24 April 2017

Browse related ATC

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
OTHER ANTINEOPLASTIC AGENTS
Monoclonal antibodies
edrecolomab
rituximab
trastuzumab
gemtuzumab
cetuximab
bevacizumab
panitumumab
catumaxomab
ofatumumab
ipilimumab
brentuximab vedotin
pertuzumab
trastuzumab emtansine
obinutuzumab
dinutuximab

Drug

Truxima (Rituximab)

ATC
Orphan drug
No

Updated 1 month ago

Unituxin (Dinutuximab)

ATC
Orphan drug
Yes

Updated 12 days ago

Gazyvaro▼ (Obinutuzumab)

ATC
Orphan drug
Yes

Updated 6 months ago

Kadcyla▼ (Trastuzumab Emtansine)

ATC
Orphan drug
No

Updated 3 months ago

Removab (Catumaxomab)

ATC
Orphan drug
No

Updated 9 months ago

Vectibix (Panitumumab)

ATC
Orphan drug
No

Updated 1 month ago

MabThera (Rituximab)

ATC
Orphan drug
No

Updated 9 months ago

Yervoy▼ (Ipilimumab)

ATC
Orphan drug
No

Updated 3 months ago

Arzerra (Ofatumumab)

ATC
Orphan drug
Yes

Updated 2 months ago

Adcetris▼ (Brentuximab vedotin)

ATC
Orphan drug
Yes

Updated 1 month ago